Straumann Holding AG (OTCMKTS:SAUHY – Get Free Report) saw a large growth in short interest during the month of October. As of October 30th, there was short interest totaling 1,042,331 shares, a growth of 3,762.9% from the October 15th total of 26,983 shares. Based on an average trading volume of 998,921 shares, the short-interest ratio is presently 1.0 days. Currently, 0.1% of the company’s stock are sold short.
Wall Street Analyst Weigh In
A number of equities analysts have issued reports on SAUHY shares. Berenberg Bank upgraded Straumann to a “strong-buy” rating in a research note on Thursday, September 17th. Deutsche Bank Aktiengesellschaft downgraded Straumann from a “buy” rating to a “hold” rating in a research note on Friday, August 21st. UBS Group raised Straumann from a “neutral” rating to a “buy” rating in a research note on Tuesday, September 1st. The Goldman Sachs Group upgraded Straumann from a “neutral” rating to a “buy” rating in a report on Monday, September 14th. Finally, Citigroup reaffirmed a “sell” rating on shares of Straumann in a research report on Wednesday, October 21st. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, one has issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy”.
Read Our Latest Report on SAUHY
Straumann Stock Performance
Shares of SAUHY traded up $0.07 on Tuesday, reaching $12.94. 32,003 shares of the company’s stock traded hands, compared to its average volume of 507,711. The stock’s 50 day simple moving average is $11.59 and its two-hundred day simple moving average is $11.67. Straumann has a 52-week low of $9.44 and a 52-week high of $13.61.
About Straumann
Straumann Group is a Swiss dental technology company that develops and supplies products and services for tooth replacement and oral tissue regeneration. Its offerings include dental implant systems, prosthetic components, biomaterials and related solutions used by dental professionals and laboratories. The company also provides digital dentistry technologies and services, including tools for treatment planning and dental restoration, as well as orthodontic products such as clear aligners through its ClearCorrect brand.
See Also
- Five stocks we like better than Straumann
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
- A $4 Billion Jolt: NRG Energy Powers Data Center Ambitions
Receive News & Ratings for Straumann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Straumann and related companies with MarketBeat.com's FREE daily email newsletter.
